<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02675634</url>
  </required_header>
  <id_info>
    <org_study_id>CP266</org_study_id>
    <nct_id>NCT02675634</nct_id>
  </id_info>
  <brief_title>Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy</brief_title>
  <official_title>Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coloplast A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coloplast A/S</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical investigation is intended to explore the performance and safety of two newly
      developed ostomy products with regard to the products fit to body properties.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fit to Body</measure>
    <time_frame>14 +/- 2 days</time_frame>
    <description>Subjects will evaluate the fit to body for each product by answering the question &quot;how was the baseplates ability to fit the body contours in the area around the stoma?&quot; The question is answered using an ordinal 5 point scale ranging from very poor to very good. The result shown below shows the fraction of subject who answered 'Good' or' Very Good' to the question.</description>
  </primary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">55</enrollment>
  <condition>Ileostomy</condition>
  <condition>Colostomy</condition>
  <arm_group>
    <arm_group_label>Test A, Test B, Subjects own product</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The subjects first test Coloplast Test A, followed by Coloplast Test B and finally Subjects own product</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test A, Subjects own product, Test B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The subjects first test Coloplast Test A, followed by Subjects own product, and finally Coloplast Test B</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test B, Test A, Subjects own product</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The subjects first test Coloplast Test B, followed by Coloplast Test A and finally Subjects own product</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test B, Subjects own product, Test A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The subjects first test Coloplast Test B, followed by Subjects own product, and finally Coloplast Test A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Subjects own product, Test A, Test B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The subjects first test Subjects own product, followed by Test A, and finally Coloplast Test B</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Subjects own product, Test B, Test A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The subjects first test Subjects own product, followed by Test B, and finally Coloplast Test A</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Coloplast Test A</intervention_name>
    <description>Test A is a new 1-piece ostomy appliance developed by Coloplast A/S</description>
    <arm_group_label>Test A, Test B, Subjects own product</arm_group_label>
    <arm_group_label>Test A, Subjects own product, Test B</arm_group_label>
    <arm_group_label>Test B, Test A, Subjects own product</arm_group_label>
    <arm_group_label>Test B, Subjects own product, Test A</arm_group_label>
    <arm_group_label>Subjects own product, Test A, Test B</arm_group_label>
    <arm_group_label>Subjects own product, Test B, Test A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Coloplast Test B</intervention_name>
    <description>Test B is a new 1-piece ostomy appliance developed by Coloplast A/S</description>
    <arm_group_label>Test A, Test B, Subjects own product</arm_group_label>
    <arm_group_label>Test A, Subjects own product, Test B</arm_group_label>
    <arm_group_label>Test B, Test A, Subjects own product</arm_group_label>
    <arm_group_label>Test B, Subjects own product, Test A</arm_group_label>
    <arm_group_label>Subjects own product, Test A, Test B</arm_group_label>
    <arm_group_label>Subjects own product, Test B, Test A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Subjects own product</intervention_name>
    <description>The comparator product is the ostomy appliance product that the subject normally uses. This could include products like SenSura , SenSura Mio, Confidence Natural, Moderma Flex and many more. data from the subject own product will be pooled so they appear as one comparator group.</description>
    <arm_group_label>Test A, Test B, Subjects own product</arm_group_label>
    <arm_group_label>Test A, Subjects own product, Test B</arm_group_label>
    <arm_group_label>Test B, Test A, Subjects own product</arm_group_label>
    <arm_group_label>Test B, Subjects own product, Test A</arm_group_label>
    <arm_group_label>Subjects own product, Test A, Test B</arm_group_label>
    <arm_group_label>Subjects own product, Test B, Test A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1. Have given written informed consent and in DK: signed a letter of authority 2. Are at
        least 18 years of age and have full legal capacity 3. Have had their ileostomy or colostomy
        for at least 3 months 4. Are able to use a baseplate cut-max 15 to 40 mm 5. Are able to
        handle the product themselves 6. Currently using a 1-piece flat product 8. Willing to use
        an open bag size maxi during the investigation 9. Are able to use a custom cut (custom fit)
        product 10. Are suitable for participating in the investigation - this means that the
        subjects must be able to follow all elements of the study procedures.

        Exclusion Criteria:

          1. Are currently receiving or have within the past 2 months received radio-and/or
             chemotherapy (low doses chemotherapy are allowed for other indications than cancer,
             e.g. below 15 mg methotrexate for rheumatoid arthritis)

          2. Are currently receiving or have within the past month received topical steroid
             treatment in the peristomal skin area, e.g. lotion or spray. Systemic steroid
             treatment (e.g. injection, or tablet) are allowed.

          3. Are pregnant or breastfeeding**

          4. Are participating in other interventional clinical investigations or have previously
             participated in this investigation

          5. Use irrigation during the investigation (flush the intestines with water, this is
             mostly for people with a colostomy)

          6. Are currently suffering from peristomal skin problems i.e. bleeding and/or broken skin
             (assessed by the investigator)

          7. Have a loop ostomy (also called double barrel ostomy)

          8. Have known hypersensitivity towards any of the products used in the investigation

               -  In DK: women in the child-bearing age will be ask to produce a negative pregnancy
                  test and to sign a form ensuring the use of safe contraception during the
                  investigation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Camilla F Vibjerg</last_name>
    <role>Study Chair</role>
    <affiliation>Head of Clinical Operation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Radiant Research</name>
      <address>
        <city>Tempe</city>
        <state>Arizona</state>
        <zip>85282</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prism research center</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>TFS</name>
      <address>
        <city>SÃ¸borg</city>
        <zip>2860</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>QPS Netherlands</name>
      <address>
        <city>Groningen</city>
        <zip>9713</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Synexus Midlands</name>
      <address>
        <city>Birmingham</city>
        <zip>B15 2SQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pilgrim Hospital</name>
      <address>
        <city>Boston</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Illingworth Research Nurses</name>
      <address>
        <city>Cheshire</city>
        <zip>Sk11 6TG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lincon Country hospital</name>
      <address>
        <city>Lincoln</city>
        <zip>LN25QY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aintree University Hospital NHS Foundation Trust</name>
      <address>
        <city>Liverpool</city>
        <zip>l9 7AL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kettering General hospital</name>
      <address>
        <city>Northamptonshire</city>
        <zip>NN168UZ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Synexus Hexam</name>
      <address>
        <city>Northumberland</city>
        <zip>NE46 1QJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>Netherlands</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 29, 2016</study_first_submitted>
  <study_first_submitted_qc>February 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 5, 2016</study_first_posted>
  <results_first_submitted>August 4, 2017</results_first_submitted>
  <results_first_submitted_qc>August 4, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">September 5, 2017</results_first_posted>
  <last_update_submitted>September 14, 2017</last_update_submitted>
  <last_update_submitted_qc>September 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The subjects were recruited through the Coloplast A/S database and from hospital sites</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Test A, Test B, Subjects Own Product</title>
          <description>The subjects first test Coloplast Test A, followed by Coloplast Test B and finally Subjects own product
Coloplast Test A: Test A is a new 1-piece ostomy appliance developed by Coloplast A/S
Coloplast Test B: Test B is a new 1-piece ostomy appliance developed by Coloplast A/S
Subjects own product: The comparator product is the ostomy appliance product that the subject normally uses. This could include products like SenSura , SenSura Mio, Confidence Natural, Moderma Flex and many more. data from the subject own product will be pooled so they appear as one comparator group.</description>
        </group>
        <group group_id="P2">
          <title>Test A, Subjects Own Product, Test B</title>
          <description>The subjects first test Coloplast Test A, followed by Subjects own product, and finally Coloplast Test B
Coloplast Test A: Test A is a new 1-piece ostomy appliance developed by Coloplast A/S
Coloplast Test B: Test B is a new 1-piece ostomy appliance developed by Coloplast A/S
Subjects own product: The comparator product is the ostomy appliance product that the subject normally uses. This could include products like SenSura , SenSura Mio, Confidence Natural, Moderma Flex and many more. data from the subject own product will be pooled so they appear as one comparator group.</description>
        </group>
        <group group_id="P3">
          <title>Test B, Test A, Subjects Own Product</title>
          <description>The subjects first test Coloplast Test B, followed by Coloplast Test A and finally Subjects own product
Coloplast Test A: Test A is a new 1-piece ostomy appliance developed by Coloplast A/S
Coloplast Test B: Test B is a new 1-piece ostomy appliance developed by Coloplast A/S
Subjects own product: The comparator product is the ostomy appliance product that the subject normally uses. This could include products like SenSura , SenSura Mio, Confidence Natural, Moderma Flex and many more. data from the subject own product will be pooled so they appear as one comparator group.</description>
        </group>
        <group group_id="P4">
          <title>Test B, Subjects Own Product, Test A</title>
          <description>The subjects first test Coloplast Test B, followed by Subjects own product, and finally Coloplast Test A
Coloplast Test A: Test A is a new 1-piece ostomy appliance developed by Coloplast A/S
Coloplast Test B: Test B is a new 1-piece ostomy appliance developed by Coloplast A/S
Subjects own product: The comparator product is the ostomy appliance product that the subject normally uses. This could include products like SenSura , SenSura Mio, Confidence Natural, Moderma Flex and many more. data from the subject own product will be pooled so they appear as one comparator group.</description>
        </group>
        <group group_id="P5">
          <title>Subjects Own Product, Test A, Test B</title>
          <description>The subjects first test Subjects own product, followed by Test A, and finally Coloplast Test B
Coloplast Test A: Test A is a new 1-piece ostomy appliance developed by Coloplast A/S
Coloplast Test B: Test B is a new 1-piece ostomy appliance developed by Coloplast A/S
Subjects own product: The comparator product is the ostomy appliance product that the subject normally uses. This could include products like SenSura , SenSura Mio, Confidence Natural, Moderma Flex and many more. data from the subject own product will be pooled so they appear as one comparator group.</description>
        </group>
        <group group_id="P6">
          <title>Subjects Own Product, Test B, Test A</title>
          <description>The subjects first test Subjects own product, followed by Test B, and finally Coloplast Test A
Coloplast Test A: Test A is a new 1-piece ostomy appliance developed by Coloplast A/S
Coloplast Test B: Test B is a new 1-piece ostomy appliance developed by Coloplast A/S
Subjects own product: The comparator product is the ostomy appliance product that the subject normally uses. This could include products like SenSura , SenSura Mio, Confidence Natural, Moderma Flex and many more. data from the subject own product will be pooled so they appear as one comparator group.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Test Period 1</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="9"/>
                <participants group_id="P4" count="9"/>
                <participants group_id="P5" count="10"/>
                <participants group_id="P6" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="8"/>
                <participants group_id="P5" count="10"/>
                <participants group_id="P6" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Device deficiency that did not lead to A</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Test Period 2</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="8"/>
                <participants group_id="P5" count="10"/>
                <participants group_id="P6" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="8"/>
                <participants group_id="P5" count="10"/>
                <participants group_id="P6" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Test Period 3</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="8"/>
                <participants group_id="P5" count="10"/>
                <participants group_id="P6" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="8"/>
                <participants group_id="P5" count="10"/>
                <participants group_id="P6" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The baseline population consist of all enrolled subjects</population>
      <group_list>
        <group group_id="B1">
          <title>The Study Population</title>
          <description>This consists of all participants who were enrolled in the study</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="55"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="55"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69" spread="11.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>One subject did not aswer the gender question therefore this information is missing.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="54"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Fit to Body</title>
        <description>Subjects will evaluate the fit to body for each product by answering the question &quot;how was the baseplates ability to fit the body contours in the area around the stoma?&quot; The question is answered using an ordinal 5 point scale ranging from very poor to very good. The result shown below shows the fraction of subject who answered 'Good' or' Very Good' to the question.</description>
        <time_frame>14 +/- 2 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Test A</title>
            <description>This is the result from all subjects evaluating Test A</description>
          </group>
          <group group_id="O2">
            <title>Test B</title>
            <description>This is the results from all the subjects evaluating Test B</description>
          </group>
          <group group_id="O3">
            <title>Own Product</title>
            <description>this is the result from all the subjects evaluating Own product.</description>
          </group>
        </group_list>
        <measure>
          <title>Fit to Body</title>
          <description>Subjects will evaluate the fit to body for each product by answering the question &quot;how was the baseplates ability to fit the body contours in the area around the stoma?&quot; The question is answered using an ordinal 5 point scale ranging from very poor to very good. The result shown below shows the fraction of subject who answered 'Good' or' Very Good' to the question.</description>
          <units>percentage of good or very good</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="54"/>
                <count group_id="O3" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93"/>
                    <measurement group_id="O2" value="88"/>
                    <measurement group_id="O3" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected from subject enrollment to the subject left the study. Subjects with serious adverse events were followed until their condition was resolved.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Test A</title>
          <description>This is the result from all subjects evaluating Test A</description>
        </group>
        <group group_id="E2">
          <title>Test B</title>
          <description>This is the results from all the subjects evaluating Test B</description>
        </group>
        <group group_id="E3">
          <title>Own Product</title>
          <description>this is the result from all the subjects evaluating Own product.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Obstibation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="54"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Peristomal skin dermatitis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="52"/>
                <counts group_id="E2" events="12" subjects_affected="11" subjects_at_risk="54"/>
                <counts group_id="E3" events="5" subjects_affected="4" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Sara Gosk</name_or_title>
      <organization>Scientific and Regulatory affairs</organization>
      <phone>+45 49113568</phone>
      <email>dksargo@coloplast.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

